These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 24798623

  • 21. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome.
    Lima BL, França AV, Pazin-Filho A, Araújo WM, Martinez JA, Maciel BC, Simões MV, Terra-Filho J, Martinelli AL.
    Mayo Clin Proc; 2004 Jan; 79(1):42-8. PubMed ID: 14708947
    [Abstract] [Full Text] [Related]

  • 22. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.
    Simbrunner B, Villesen IF, Scheiner B, Paternostro R, Schwabl P, Stättermayer AF, Marculescu R, Pinter M, Quehenberger P, Trauner M, Karsdal M, Lisman T, Reiberger T, Leeming DJ, Mandorfer M.
    Hepatol Int; 2023 Dec; 17(6):1532-1544. PubMed ID: 37605068
    [Abstract] [Full Text] [Related]

  • 23. The predictive value of Von Willebrand factor antigen plasma levels in children with acute lung injury.
    El Basset Abo El Ezz AA, Abd El Hafez MA, El Amrousy DM, El Momen Suliman GA.
    Pediatr Pulmonol; 2017 Jan; 52(1):91-97. PubMed ID: 27362747
    [Abstract] [Full Text] [Related]

  • 24. Hepatopulmonary syndrome.
    Koch DG, Fallon MB.
    Clin Liver Dis; 2014 May; 18(2):407-20. PubMed ID: 24679503
    [Abstract] [Full Text] [Related]

  • 25. Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry.
    Deibert P, Allgaier HP, Loesch S, Müller C, Olschewski M, Hamm H, Maier KP, Blum HE.
    BMC Gastroenterol; 2006 Apr 25; 6():15. PubMed ID: 16638132
    [Abstract] [Full Text] [Related]

  • 26. Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.
    Lejealle C, Paradis V, Bruno O, de Raucourt E, Francoz C, Soubrane O, Lebrec D, Bedossa P, Valla D, Mal H, Vilgrain V, Durand F, Rautou PE.
    Chest; 2019 Jan 25; 155(1):123-136. PubMed ID: 30292761
    [Abstract] [Full Text] [Related]

  • 27. Hepatopulmonary syndrome in patients with hypoxic hepatitis.
    Fuhrmann V, Madl C, Mueller C, Holzinger U, Kitzberger R, Funk GC, Schenk P.
    Gastroenterology; 2006 Jul 25; 131(1):69-75. PubMed ID: 16831591
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction.
    Gupta D, Vijaya DR, Gupta R, Dhiman RK, Bhargava M, Verma J, Chawla YK.
    Am J Gastroenterol; 2001 Dec 25; 96(12):3395-9. PubMed ID: 11774955
    [Abstract] [Full Text] [Related]

  • 29. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy S, Lim SJ, Murphy RP, McCabe D.
    J Neurol Sci; 2017 Apr 15; 375():404-410. PubMed ID: 28320178
    [Abstract] [Full Text] [Related]

  • 30. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P.
    Hepatology; 2020 Aug 15; 72(2):584-594. PubMed ID: 31773739
    [Abstract] [Full Text] [Related]

  • 31. Utility of pulse oximetry screening for hepatopulmonary syndrome.
    Arguedas MR, Singh H, Faulk DK, Fallon MB.
    Clin Gastroenterol Hepatol; 2007 Jun 15; 5(6):749-54. PubMed ID: 17392034
    [Abstract] [Full Text] [Related]

  • 32. Serum bile acids in patients with hepatopulmonary syndrome.
    Horvatits T, Drolz A, Rutter K, Roedl K, Fauler G, Müller C, Kluge S, Trauner M, Schenk P, Fuhrmann V.
    Z Gastroenterol; 2017 Apr 15; 55(4):361-367. PubMed ID: 27951601
    [Abstract] [Full Text] [Related]

  • 33. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease.
    Pomej K, Scheiner B, Balcar L, Nussbaumer RJ, Weinzierl J, Paternostro R, Simbrunner B, Bauer D, Pereyra D, Starlinger P, Stättermayer AF, Pinter M, Trauner M, Quehenberger P, Reiberger T, Mandorfer M.
    Dig Liver Dis; 2022 Oct 15; 54(10):1376-1384. PubMed ID: 35871985
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
    Roberts DN, Arguedas MR, Fallon MB.
    Liver Transpl; 2007 Feb 15; 13(2):206-14. PubMed ID: 17205561
    [Abstract] [Full Text] [Related]

  • 35. Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension.
    Møller S, Krag A, Madsen JL, Henriksen JH, Bendtsen F.
    Liver Int; 2009 Nov 15; 29(10):1528-37. PubMed ID: 19725890
    [Abstract] [Full Text] [Related]

  • 36. Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation.
    Flori HR, Ware LB, Milet M, Matthay MA.
    Pediatr Crit Care Med; 2007 Mar 15; 8(2):96-101. PubMed ID: 17273112
    [Abstract] [Full Text] [Related]

  • 37. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
    Maieron A, Salzl P, Peck-Radosavljevic M, Trauner M, Hametner S, Schöfl R, Ferenci P, Ferlitsch M.
    Aliment Pharmacol Ther; 2014 Feb 15; 39(3):331-8. PubMed ID: 24308724
    [Abstract] [Full Text] [Related]

  • 38. The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis.
    Pan Y, Guo R, Lv Y, Cui D, Xie J.
    Can J Gastroenterol Hepatol; 2022 Feb 15; 2022():9035971. PubMed ID: 35360443
    [Abstract] [Full Text] [Related]

  • 39. Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
    Douschan P, Kovacs G, Sassmann T, Stadlbauer V, Avian A, Foris V, Tatscher E, Durchschein F, Rainer F, Spindelboeck W, Wagner M, Kniepeiss D, Zollner G, Bachmaier G, Fickert P, Olschewski H, Stauber RE.
    Respir Med; 2022 Oct 15; 202():106987. PubMed ID: 36115317
    [Abstract] [Full Text] [Related]

  • 40. Prevalence and characteristics of hepatopulmonary syndrome in children with cirrhosis in southern Brazil.
    Ceza MR, Garcia E, Anselmi CE, Epifanio M, Melere MU, Ferreira CT, Steinhaus C, Coral GP.
    Eur J Gastroenterol Hepatol; 2019 Jan 15; 31(1):10-15. PubMed ID: 30045096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.